News for hackers. Stuff that matters.

A comment on Kim Jung Gi has died. Parent comment

Re:Kim Jung Gi has died by walterbell on Friday October 07, 2022 @03:25AM (#33118358)
> Practically, it is not experiment.

The U.S. NIH says otherwise, e.g. here is one of the ongoing clinical studies, which continues through March 2023, https://clinicaltrials.gov/ct2/show/NCT04848584

  Study Type: Observational
  Official Title: Pfizer-BioNTech COVID-19 BNT162b2 Vaccine Effectiveness Study - Kaiser Permanente Southern California
  Actual Study Start Date:  May 15, 2021
  Estimated Primary Completion Date: March 31, 2023
  Estimated Study Completion Date: March 31, 2023
> covid-19 vaccines

WHO lists 11 vaccines and 4 types, each with different mechanisms of action, effectiveness and safety, https://covid19.trackvaccines.org/agency/who/

  Protein subunit
  RNA
  Non Replicating Viral Vector
  Inactivated Virus
[ Parent | on HN ]
Re:Kim Jung Gi has died by watwut on Friday October 07, 2022 @07:32PM (#33128260)
There being ongoing related studies does not mean the whole vaccination thing is experiment. The level of manipulativeness and appeals to emotions rather then logic are super high higher.

Also there are way more then just 11 vaccines all in all.

[ Parent | on HN ]
Re:Kim Jung Gi has died by walterbell on Saturday October 08, 2022 @05:43PM (#33136290)
> ongoing related studies does not mean the whole vaccination thing is experiment

It means that the outcome of vaccine studies which complete in 2023, e.g. medium-term adverse effects, identification of specific risk pools, mitigations for adverse effects, will primarily benefit those who receive treatment after the studies complete in 2023.

Any beneficial information from a study completing in 2023 would self-evidently not be available in 2021 and 2022, i.e. science would have yielded new scientific knowledge. Participating in an ongoing scientific procedure with partial data is a risk-benefit decision, but that does not make it any less of an experiment, when there is ongoing, parallel research, clinical trials and scientists working diligently to answer open questions.

[ Parent | on HN ]